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Abstract
Purpose In Gustilo grade III open fractures, it remains un-
known which demographic or clinical features may be asso-
ciated with an infection resistant to the administered prophy-
lactic agent, compared to one that is susceptible.
Methods This was a retrospective case–control study on pa-
tients hospitalized from 2004 to 2009.
Results We identified 310 patients with Gustilo-III open frac-
tures, 36 (12 %) of which became infected after a median of
ten days. In 26 (72 %) of the episodes the pathogen was
susceptible to the prophylactic antibiotic agent prescribed upon
admission, while in the other ten it was resistant. All antibiotic
prophylaxis was intravenous; the median duration of treatment
was three days and the median delay between trauma and
surgery was one day. In multivariate analysis adjusting for
case-mix, only Gustilo-grade-IIIc fractures (vascular lesions)
showed tendency to be infected with resistant pathogens (odds
ratio 10; 95 % confidence interval 1.0–10; p=0.058). There
were no significant differences between cases caused by anti-
biotic resistant and susceptible pathogen cases in patient’s sex,
presence of immune suppression, duration and choice of anti-
biotic prophylaxis, choice of surgical technique or materials,
time delay until surgery, use of bone reaming, fracture locali-
zation, or presence of compartment syndrome.
Conclusion We were unable to identify any specific clinical
parameters associated with infection with antibiotic resistant
pathogens in Gustilo-grade III open fractures, other than the
severity of the fracture itself. More research is needed to
identify patients who might benefit from a broader-spectrum
antibiotic prophylaxis.
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Introduction
Gustilo grade III open fractures are associated with a substan-
tial infection risk due to naturally resistant pathogens such as
Pseudomonas aeruginosa or Enterobacter spp (up to 33 % in
grade IIIc fractures alone; and between 10 and 15 % for the
entire group of grade III fractures) [1–3]. The optimal pre-
scription of antibiotic prophylaxis is of utmost importance, but
remains largely unknown when it comes to evidence-based
recommendations for duration and choice of agents. Probably,
administration for more than three days does not reduce
infection risk compared to shorter regimens [1], even in severe
Grade-IIIc fractures with vascular injury. Regarding the
choice of antibiotic agents, practice prefers second generation
cephalosporins alone [1, 2, 4, 5], or combined with
aminogylcosides [1, 2, 6], quinolones [1, 3] or rarely regimens
for eventual anaerobic pathogens [7]. However, despite large
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Table 1 Infecting pathogens of Gustilo III open fractures stratified upon antibiotic resistance to first and second generation cephalosporins and
amoxicillin/clavunalate
Characteristic Susceptible (n=26) Resistant (n=10) p valuea
Gender
Female 4 1
Male 22 9 1.000
Psychiatric comorbidities 6 3 0.686
Age (years)
<29 y 7 3
30–41 y 10 4
42–59 y 8 2
≥60 y 1 1 0.844
Active cancer
No 25 10




IIIc 13 7 0.599
Type of boneb
Long 2 2
Short 24 8 0.305
Fracture localization
Above knee 18 6 1.000
Tibia 8 4 0.700
Arm 2 1 1.000
Antibiotic prophylaxis
1st and 2nd generation cephalosporins
No 9 2
Yes 17 8 0.394
More than one antibiotic agent
No 13 3
Yes 13 7 0.456
Carbapenem prophylaxis
No 23 10
Yes 3 0 0.545
Anaerobes’ prophylaxis
No 13 8
Yes 6 2 0.675
Gram-negative prophylaxis
No 14 8
Yes 5 2 1.000
Prophylaxis against MRSA
No 26 9
Yes 0 1 0.279
Duration of antibiotic prophylaxis
Single shot 4 1
1–3 days 11 3
4–5 days 4 2
>5 days 7 4 0.819
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antibiotic coverage, infection still occurs and it remains un-
known why some infections are resistant to the administered
prophylactic agents, while others are not.
Methods
In this single-centre study from 2004 to 2009 at Geneva
University Hospitals, we assessed clinical variables associated
with resistant pathogens in Gustilo-III open fractures.
Formally, resistance was defined as antibiotic resistance of
the later pathogen towards the prior administered antimicro-
bial agent(s), but practically it was equivalent with resistance
to aminopenicillins and generation I-II cephalosprins. The
classification of open fractures was based on the original
papers of Gustilo and Anderson [2]. Infection was defined
when pus was present also when surgical and antibiotic care
was considered necessary for the treatment of the infection.
Patients aged <18 years and those with a follow-up shorter
than 60 days were excluded. Furthermore, patients were also
excluded with infections occurring after two months of the
first surgical treatment or during a subsequent hospitalization,
because they were arbitrarily considered as hospital-acquired
(and potentially unrelated to the traumatic contamination). For
open fracture treated in our institution, priority is given to
damage control, vascular repair, skeletal stabilization,
irrigation with at least 9 L of normal saline and administration
of antibiotic prophylaxis using cefuroxime (1.5 g tid) or
amoxicillin-clavulanate (1.2 g tid). Second look surgery is
often performed after 48 h, and definitive osteosynthesis is
performed later. Nevertheless, despite written recommenda-
tions, treating physicians and anaesthetists are free to choose
the agent of initial prophylaxis. Especially during the early
study period, many surgeons stem from different countries
with a variety of personal experiences in the management of
open fractures. This was part of an internal quality assessment
project supported by studies approved by the local Ethical
Committee [1].
Results
We identified 310 patients (median age 39 years; five females;
one immune-suppressed patient due to active cancer) with
Gustilo-III open fractures (63 grade IIIa, 53 grade IIIb, 63
grade IIIc, and 131 episodes without clear subgradification
into a or b in surgical files). Only 36 episodes (12 %) became
infected after a median of ten days after admission. Patients
were followed through 31December 2011, e.g. until two years
after the inclusion of the last patient [1]. All patients were
treated surgically with a median number of two interventions
(range, 1–9) and a median delay between trauma and first
Table 1 (continued)




Yes 2 2 0.572
Plate osteosynthesis
No 23 9
Yes 3 1 1.000
Vascular repair
No 13 2
Yes 13 8 0.142
Fasciotomy (compartment syndrome)
No 19 6
Yes 7 4 0.454
Primary closure (no second look)
No 19 7
Yes 7 3 1.000
Time delay trauma to surgery
0 days 13 9
1 day 2 0
>2 days 11 1 0.199
a Group comparisons per Pearson-chi² or Fisher's exact test, as appropriate
b Long bones=humerus, radius, ulna, femur, tibia, and fibula
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surgery of 0 days (interquartile range (IQR), 0–1). All
patients received systemic prophylactic parenteral antibi-
otics for a median duration of three days (IQR, 3–6).
No antibiotic-loaded beads or other devices allowing
local antibiotic therapy were used, and there was no
targeted therapy, e.g. identification of potential future
pathogens during the first surgical access with conse-
quent pre-emptive therapy [1]. Cefuroxime alone was
the most frequently prescribed regimen (n=215;
69 %). Empirical carbapenems were involved in three
cases. Among 54 combined prophylactic regimens, sev-
en were planned to cover non-fermenting rods, seven
were designed for potential anaerobes, and one episode
covered potential methicillin-resistant S. aureus.
In 26 (72 %) episodes, the pathogen was susceptible to the
prophylactic antibiotic agent prescribed upon admission.
Susceptible pathogens were mostly Enterobacter cloacae
(n=8), and Pseudomonas spp (n=8), followed by Bacillus
spp (n=6). In contrast, the infecting pathogen was resistant
to prior antibiotic treatment in the other ten cases
[Pseudomonas aeruginosa (n=4), Enterococcus faecalis (n=
4), Enterobacter cloacae (n=4), and others (Table 1)]. In the
multivariate model [8] adjusting for case-mix (Table 2; accu-
racy with a receiver-operating curve (ROC) value of 0.82),
only Gustilo-IIIc fractures (vascular lesions) showed tendency
to be infected with resistant pathogens (odds ratio 10; 95 %
confidence interval 1.0–10.0; p=0.058). There were no
significant differences between cases caused by antibi-
otic resistant and susceptible pathogen cases in: patient’s
gender, presence of immune suppression, duration and
choice of antibiotic prophylaxis, choice of surgical tech-
nique or materials, primary surgical closure, time delay
until surgery, use of bone reaming, fracture localization,
or presence of compartment syndrome.
Discussion
We were unable to identify any specific clinical parameter
associated with infection due to resistant or susceptible
Table 2 Clinical variables associated with susceptible infection in open fractures Gustilo grade III (unmatched logistic regression analysis)
Characteristic Univariate analysis Multivariate analysis
Variable Odds ratio (95 % CI) p-value Odds ratio (95 % CI) p-value
Female gender 1.6 (0.2–16.7) 0.678 n.a.
Psychiatric comorbidities 0.7 (0.1–3.6) 0.668 n.a.
Age (continuous variables)
>29 years and ≤42 years 1.1 (0.2–6.4) 0.939 n.a.
>42 years and ≤60 years 1.7 (0.2–13.4) 0.608 n.a.
>60 years 0.4 (0.0–9.4) 0.590 n.a
Summer period 2.4 (0.5–10.7) 0.250 0.57 (0.1–10.1) 0.670
Grade IIIc fracture 0.1 (0.1–1.2) 0.145 0.1 (0.0–1.1) 0.058
Compartment syndrome 0.6 (0.1–2.9) 0.540 0.4 (0.1–13.3) 0.606
Vascular repair 0.3 (0.1–1.9) 0.209 n.a
Long bone fracturea 3 (0.3–24.9) 0.309 n.a.
Fracture below knee 1.0 (0.2–4.7) 0.960 n.a.
Tibia fracture 1.5 (0.3–6.8) 0.600 1.5 (0.1–24.9) 0.774
Arm fracture 0.8 (0.1–9.3) 0.823 n.a.
Cephalosporin prophylaxis 3.9 (0.6–23.8) 0.142 n.a.
Prophylaxis targeting anaerobes 3.7 (0.4–36.5) 0.264 n.a.
Prophylaxis against Gram-negative rods 1.3 (0.2–8.1) 0.815 n.a.
Prophylaxis with two agents 1.6 (0.3–10.2) 0.610 n.a.
Prophylaxis duration
2–3 days compared to 1 day 0.9 (0.1–11.6) 0.946 2.2 (0.1–72.7) 0.667
≥5 days compared to 1 day 0.4 (0.4–5.4) 0.519 0.7 (0.1–21.7) 0.859
Reaming 0.4 (0.1–3.5) 0.425 n.a.
Primary closure 2.3 (0.2–25.2) 0.487 n.a.
Plate osteosynthesis 1.4 (0.1–15.6) 0.774 n.a.
a Long bones=humerus, radius, ulna, femur, tibia, and fibula
n.a. not available
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pathogens in Gustilo-grade-III open fractures, with the note-
worthy exception of the severity of the fracture itself. In our
retrospective study cited in the beginning of the manuscript
[1], 71 % of infections with grade III fractures were due to
pathogens presumably selected by the antibiotic agents used.
However, a combination of cephalosporins with aminoglyco-
sides, quinolones, metronidazole, vancomycin or carbapen-
ems equally failed to reveal a protective effect in all univariate
analyses, underlining that the use of a larger antibiotic cover-
age is not a guarantee for absence of subsequent infection.
Open fractures are contaminated by a large variety of
antibiotic-susceptible pathogens, including P. aeruginosa
and S. aureus [1]. Thus, it seems unpredictable which patho-
gen will be selected by ongoing antibiotic prophylaxis. A
hypothetical large antibiotic coverage including glycopeptides
and carbapenems is not feasible and would be very costly [1]
for every grade III open fracture. Additionally, it is not granted
that even maximal antibiotic coverage would prevent
infection, especially in tissues with debris and reduced
blood circulation. As the consequence of our internal evalua-
tion, we therefore renounce to change our empirical antibiotic
recommendations until future randomized trials might
identify patients who could benefit from a broader-spectrum
prophylaxis [9].
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